Showing results (71-80 of 100) with videos related to
Sort By:
Pageof 10
International Journal of Molecular Sciences|January 10, 2026
Immune-Based Biomarkers as Predictors of Mortality in ECMO Therapy for Severe COVID-19 ARDS: Insights from a Retrospective StudyRosalia Busà, Giovanna Panarello, Alessia Gallo, et al.Frontiers in Oncology|October 3, 2022
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approachAntonella Fameli, Valerio Nardone, Mojtaba Shekarkar Azgomi, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 10, 2013
Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: the GOLFIG-2 multicentric open-label randomized phase III trialPierpaolo Correale, Cirino Botta, Maria S Rotundo, et al.International Journal of Molecular Sciences|June 12, 2026
Coevolution of NK and Tumor Cell States Along Multiple Myeloma Progression from Precursor ConditionsCristina Aquilina, Andrea Romano, Anna Maria Corsale, et al.Cell Death & Disease|June 17, 2021
Clobetasol promotes neuromuscular plasticity in mice after motoneuronal loss via sonic hedgehog signaling, immunomodulation and metabolic rebalancingNunzio Vicario, Federica M Spitale, Daniele Tibullo, et al.Blood Cancer Journal|December 15, 2021
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignanciesLuis-Esteban Tamariz-Amador, Anna Martina Battaglia, Catarina Maia, et al.Frontiers in Oncology|November 30, 2019
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-UpMichele Caraglia, Pierpaolo Correale, Rocco Giannicola, et al.Blood Neoplasia|January 2, 2026
Bone marrow immune cell composition reflects multiple myeloma progression and affects treatment responseAnna Maria Corsale, Mojtaba Shekarkar Azgomi, Emilia Gigliotta, et al.Haematologica|December 17, 2020
Immunologic characterization of COVID-19 patients with hematological cancerCatarina Maia, Esperanza Martín-Sánchez, Juan José Garcés, et al.Blood|March 29, 2024
Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myelomaAnnamaria Gulla, Eugenio Morelli, Megan Johnstone, et al.Pageof 10